keyword
https://read.qxmd.com/read/38534663/polylactic-glycolic-acid-mediated-delivery-of-plectasin-derivative-nz2114-in-staphylococcus-epidermidis-biofilms
#21
JOURNAL ARTICLE
Xuanxuan Ma, Na Yang, Ruoyu Mao, Ya Hao, Da Teng, Yinhua Huang, Jianhua Wang
Antimicrobial peptides (AMPs) are antibiotic candidates; however, their instability and protease susceptibility limit clinical applications. In this study, the polylactic acid-glycolic acid (PLGA)-polyvinyl alcohol (PVA) drug delivery system was screened by orthogonal design using the double emulsion-solvent evaporation method. NZ2114 nanoparticles (NZ2114-NPs) displayed favorable physicochemical properties with a particle size of 178.11 ± 5.23 nm, polydispersity index (PDI) of 0.108 ± 0.10, ζ potential of 4...
February 29, 2024: Antibiotics
https://read.qxmd.com/read/38528476/long-term-treatment-with-lasmiditan-in-patients-with-migraine-post-hoc-analysis-of-treatment-patterns-and-outcomes-from-the-open-label-extension-of-the-centurion-randomized-trial
#22
RANDOMIZED CONTROLLED TRIAL
Mika Komori, Akichika Ozeki, Yuka Tanji, Eriko Kamiki, John H Krege, Lily Qian Li, Shiho Suzuki, Mamoru Shibata, Takao Takeshima
BACKGROUND: The objective of this analysis was to gain new insights into the patient characteristics and other factors associated with lasmiditan usage and clinical outcomes under conditions resembling the real-world setting. METHODS: This was a post hoc analysis of data from the 12-month, open-label extension (OLE) of the phase 3, double-blind, randomized, controlled CENTURION trial, which examined the efficacy and safety of lasmiditan as acute treatment across four migraine attacks...
March 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38527614/the-impact-of-the-fluconazole-trailing-effect-on-the-persistence-of-candida-albicans-bloodstream-infection-when-treated-with-fluconazole
#23
JOURNAL ARTICLE
Shang-Yi Lin, Ho-Yin Huang, Lin-Li Chang, Ya-Ling Wang, Tun-Chieh Chen, Ko Chang, Hung-Pin Tu, Po-Liang Lu
OBJECTIVES: The trailing effect of Candida species is a phenomenon characterized by reduced but persistent growth at antifungal concentrations above the minimal inhibitory concentration (MIC). We assessed the impact of trailing growth on the persistence of Candida albicans candidemia in patients receiving fluconazole therapy. METHODS: We retrospectively investigated candidemia isolates at three hospitals in southern Taiwan between 2013 and 2020. Patients treated with fluconazole for fluconazole-susceptible C...
March 23, 2024: Clinical Microbiology and Infection
https://read.qxmd.com/read/38525093/nivolumab-safety-in-renal-cell-carcinoma-a-case-report
#24
James Debono, Dustin Balzan, John Joseph Borg, Stephen Falzon, Dania Al-Haddad, Benjamin Micallef, Janet Sultana
Nivolumab is used to treat several different types of cancers. Although it is generally considered to be effective and well-tolerated, it has been associated with adverse effects requiring discontinuation of treatment, like many other drugs used for cancer. A 70-year-old male was switched from sunitinib to nivolumab for renal cell carcinoma. The patient developed persistent hypothyroidism, onycholysis, and pneumonitis at nivolumab cycle 6, 10, and 11, respectively. Using the Naranjo causality method, the likelihood of causality was deemed "probable" for pneumonitis and hypothyroidism and "possible" for onycholysis...
April 2024: Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians
https://read.qxmd.com/read/38524205/gestational-diabetes-mellitus-in-pregnancies-conceived-after-infertility-treatment-a-population-based-study-in-the-united-states-2015-2020
#25
JOURNAL ARTICLE
Devika Sachdev, Mark V Sauer, Cande V Ananth
OBJECTIVE: To evaluate the risk of gestational diabetes mellitus (GDM) in singleton pregnancies conceived using infertility treatment and examine the influence of race and ethnicity as well as prepregnancy body mass index (BMI). DESIGN: Cross-sectional study using the US vital records data of women that delivered singleton births. SETTING: United States, 2015-2020. INTERVENTIONS: Any infertility treatment was divided into two groups: those that used fertility-enhancing drugs, artificial insemination, or intrauterine insemination, and those that used assisted reproductive technology (ART)...
March 2024: F&S reports
https://read.qxmd.com/read/38521844/diverse-functions-of-cytochrome-c-in-cell-death-and-disease
#26
REVIEW
Zhuan Zhou, Tasnim Arroum, Xu Luo, Rui Kang, Yong J Lee, Daolin Tang, Maik Hüttemann, Xinxin Song
The redox-active protein cytochrome c is a highly positively charged hemoglobin that regulates cell fate decisions of life and death. Under normal physiological conditions, cytochrome c is localized in the mitochondrial intermembrane space, and its distribution can extend to the cytosol, nucleus, and extracellular space under specific pathological or stress-induced conditions. In the mitochondria, cytochrome c acts as an electron carrier in the electron transport chain, facilitating adenosine triphosphate synthesis, regulating cardiolipin peroxidation, and influencing reactive oxygen species dynamics...
March 23, 2024: Cell Death and Differentiation
https://read.qxmd.com/read/38516133/spotlight-on-eltrombopag-concentration-in-pediatric-immune-thrombocytopenia-a-single-center-observational-study-in-china
#27
JOURNAL ARTICLE
Shuyue Dong, Zhifa Wang, Nan Wang, Jingyao Ma, Jinxi Meng, Yixin Sun, Xiaoling Cheng, Runhui Wu
IMPORTANCE: Eltrombopag has been recommended for pediatric immune thrombocytopenia (ITP). Response and adverse drug reactions (ADRs) varied widely between individuals, even at the same dose of eltrombopag. The appropriate eltrombopag concentration in ITP has not been reported. OBJECTIVE: This study aims to explore the appropriate eltrombopag concentration in pediatric ITP. METHODS: This was a single-center, prospective cohort study. Children diagnosed with refractory persistent/chronic ITP and platelet count < 30×109 /L were treated with eltrombopag and followed up for at least 2 months...
March 2024: Pediatric Investigation
https://read.qxmd.com/read/38508915/mavacamten-a-novel-agent-for-hypertrophic-cardiomyopathy
#28
REVIEW
J Chase Cole, Samantha F Benvie, Marci DeLosSantos
PURPOSE: Hypertrophic cardiomyopathy (HCM) is an under-recognized genetic cardiac disorder affecting the muscles and contractility of the heart, which in turn can result in heart failure symptoms, arrhythmia, and sudden cardiac death. Previously, pharmacotherapy options for HCM were not disease-specific, often poorly tolerated, and overall inadequate for optimal management. This narrative review discusses the pharmacology of the novel drug mavacamten, the clinical trials supporting its use, and considerations for its use in clinical practice...
March 19, 2024: Clinical Therapeutics
https://read.qxmd.com/read/38508142/targeting-of-vulnerabilities-of-drug-tolerant-persisters-identified-through-functional-genetics-delays-tumor-relapse
#29
JOURNAL ARTICLE
Mengnuo Chen, Sara Mainardi, Cor Lieftink, Arno Velds, Iris de Rink, Chen Yang, Hendrik J Kuiken, Ben Morris, Finn Edwards, Fleur Jochems, Olaf van Tellingen, Manon Boeije, Natalie Proost, Robin A Jansen, Shifan Qin, Haojie Jin, J C Koen van der Mijn, Arnout Schepers, Subramanian Venkatesan, Wenxin Qin, Roderick L Beijersbergen, Liqin Wang, René Bernards
Drug-tolerant persisters (DTPs) are a rare subpopulation of cells within a tumor that can survive therapy through nongenetic adaptive mechanisms to develop relapse and repopulate the tumor following drug withdrawal. Using a cancer cell line with an engineered suicide switch to kill proliferating cells, we perform both genetic screens and compound screens to identify the inhibition of bromodomain and extraterminal domain (BET) proteins as a selective vulnerability of DTPs. BET inhibitors are especially detrimental to DTPs that have reentered the cell cycle (DTEPs) in a broad spectrum of cancer types...
March 19, 2024: Cell reports medicine
https://read.qxmd.com/read/38503235/the-role-of-amino-acid-metabolism-in-autoimmune-hepatitis
#30
REVIEW
Xiaorong Xiang, Qihong Li, Jiajia Wan, Chao Chen, Mengmeng Guo, Zhixu He, Donghong Wang, Xu Zhao, Lin Xu
Autoimmune hepatitis (AIH) is an inflammatory chronic liver disease with persistent and recurrent immune-mediated liver injury. The exact cause of AIH is still not fully understood, but it is believed to be primarily due to an abnormal activation of the immune system, leading to autoimmune injury caused by the breakdown of autoimmune tolerance. Although the pathogenesis of AIH remains unclear, recent studies have shown that abnormalities in amino acid metabolism play significant roles in its development. These abnormalities in amino acid metabolism can lead to remodeling of metabolic processes, activation of signaling pathways, and immune responses, which may present new opportunities for clinical intervention in AIH...
March 18, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38503004/circular-rnas-in-the-kras-pathway-emerging-players-in-cancer-progression
#31
REVIEW
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, Pooja Bansal, Harpreet Kaur, Mahamedha Deorari, Haider Ali, Moyad Shahwan, Waleed Hassan Almalki, Imran Kazmi, Sami I Alzarea, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta
Circular RNAs (circRNAs) have been recognized as key components in the intricate regulatory network of the KRAS pathway across various cancers. The KRAS pathway, a central signalling cascade crucial in tumorigenesis, has gained substantial emphasis as a possible therapeutic target. CircRNAs, a subgroup of non-coding RNAs known for their closed circular arrangement, play diverse roles in gene regulation, contributing to the intricate landscape of cancer biology. This review consolidates existing knowledge on circRNAs within the framework of the KRAS pathway, emphasizing their multifaceted functions in cancer progression...
March 11, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38501869/echinocandin-persistence-directly-impacts-the-evolution-of-resistance-and-survival-of-the-pathogenic-fungus-candida-glabrata
#32
JOURNAL ARTICLE
Amir Arastehfar, Farnaz Daneshnia, Daniel J Floyd, Nathan Elias Jeffries, Mostafa Salehi, David S Perlin, Macit Ilkit, Cornelia Lass-Flöerl, Michael K Mansour
UNLABELLED: Recent epidemiological studies documented an alarming increase in the prevalence of echinocandin-resistant (ECR) Candida glabrata blood isolates. ECR isolates are known to arise from a minor subpopulation of a clonal population, termed echinocandin persisters. Although it is believed that isolates with a higher echinocandin persistence (ECP) are more likely to develop ECR, the implication of ECP needs to be better understood. Moreover, replacing laborious and time-consuming traditional approaches to determine ECP levels with rapid, convenient, and reliable tools is imperative to advance our understanding of this emerging concept in clinical practice...
March 19, 2024: MBio
https://read.qxmd.com/read/38500139/bigger-problems-from-smaller-colonies-emergence-of-antibiotic-tolerant-small-colony-variants-of-mycobacterium-avium-complex-in-mac-pulmonary-disease-patients
#33
JOURNAL ARTICLE
Hyun-Eui Park, Kyu-Min Kim, Minh Phuong Trinh, Jung-Wan Yoo, Sung Jae Shin, Min-Kyoung Shin
BACKGROUND: Mycobacterium avium complex (MAC) is a group of slow-growing mycobacteria that includes Mycobacterium avium and Mycobacterium intracellulare. MAC pulmonary disease (MAC-PD) poses a threat to immunocompromised individuals and those with structural pulmonary diseases worldwide. The standard treatment regimen for MAC-PD includes a macrolide in combination with rifampicin and ethambutol. However, the treatment failure and disease recurrence rates after successful treatment remain high...
March 18, 2024: Annals of Clinical Microbiology and Antimicrobials
https://read.qxmd.com/read/38496111/should-the-left-atrial-appendage-closure-laac-technique-be-the-main-form-of-stroke-prevention-in-patients-with-long-standing-persistent-or-permanent-atrial-fibrillation
#34
Thebuoshon Amalathasan, Pooja A Nagaratnam, Mirna El Dirani, Julius M Nagaratnam, Samer Kholoki
Currently, oral anticoagulants are considered the gold standard for stroke prevention in patients with atrial fibrillation. Despite the efficacy of oral anticoagulants in reducing stroke incidence, patients are at risk of developing adverse reactions such as excessive bleeding and bruising, and can also have drug-drug interactions. In the early 2000s, a minimally invasive technique called the left atrial appendage closure emerged as an alternative for stroke prevention in atrial fibrillation patients who could not tolerate oral anticoagulants...
February 2024: Curēus
https://read.qxmd.com/read/38485491/targeting-mycobacterium-tuberculosis-persistence-through-inhibition-of-the-trehalose-catalytic-shift
#35
JOURNAL ARTICLE
Karishma Kalera, Rachel Liu, Juhyeon Lim, Rasangi Pathirage, Daniel H Swanson, Ulysses G Johnson, Alicyn I Stothard, Jae Jin Lee, Anne W Poston, Peter J Woodruff, Donald R Ronning, Hyungjin Eoh, Benjamin M Swarts
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death worldwide by infectious disease. Treatment of Mtb infection requires a six-month course of multiple antibiotics, an extremely challenging regimen necessitated by Mtb's ability to form drug-tolerant persister cells. Mtb persister formation is dependent on the trehalose catalytic shift, a stress-responsive metabolic remodeling mechanism in which the disaccharide trehalose is liberated from cell surface glycolipids and repurposed as an internal carbon source to meet energy and redox demands...
March 14, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38482995/dose-safety-and-pharmacodynamics-of-subcutaneous-bupivacaine-in-a-novel-extended-release-microparticle-formulation-a-phase-1-dose-ascending-study-in-male-volunteers
#36
JOURNAL ARTICLE
Elisabeth Kjaer Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Ida Klitzing Storgaard, Trine Meldgaard Lund, Kirsten Møller, Mads Utke Werner
A novel microparticle-based extended-release local anaesthetic containing a bupivacaine/poly-lactic-co-glycolic acid (PLGA; LIQ865A) or plain bupivacaine (LIQ865B) was examined in a first-in-human trial. The objectives were to examine the dose safety/tolerability and pharmacodynamics. Randomized subcutaneous injections of LIQ865A (n = 16) or LIQ865B (n = 12) and diluent, contralaterally, were administered in a dose-ascending manner (150- to 600-mg bupivacaine). Subjects were admitted 24 h post-injection and followed for 30 days post-injection...
March 14, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38475923/clinical-safety-and-feasibility-of-a-novel-implantable-neuroimmune-modulation-device-for-the-treatment-of-rheumatoid-arthritis-initial-results-from-the-randomized-double-blind-sham-controlled-reset-ra-study
#37
JOURNAL ARTICLE
Daniel Peterson, Mark Van Poppel, Warren Boling, Perry Santos, Jason Schwalb, Howard Eisenberg, Ashesh Mehta, Heather Spader, James Botros, Frank D Vrionis, Andrew Ko, P David Adelson, Bradley Lega, Peter Konrad, Guillermo Calle, Fernando L Vale, Richard Bucholz, R Mark Richardson
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that causes persistent synovitis, bone damage, and progressive joint destruction. Neuroimmune modulation through electrical stimulation of the vagus nerve activates the inflammatory reflex and has been shown to inhibit the production and release of inflammatory cytokines and decrease clinical signs and symptoms in RA. The RESET-RA study was designed to determine the safety and efficacy of an active implantable device for treating RA...
March 13, 2024: Bioelectronic Medicine
https://read.qxmd.com/read/38473364/induction-of-multiple-alternative-mitogenic-signaling-pathways-accompanies-the-emergence-of-drug-tolerant-cancer-cells
#38
JOURNAL ARTICLE
Frank V Celeste, Scott Powers
Drug resistance can evolve from a subpopulation of cancer cells that initially survive drug treatment and then gradually form a pool of drug-tolerant cells. Several studies have pinpointed the activation of a specific bypass pathway that appears to provide the critical therapeutic target for preventing drug tolerance. Here, we take a systems-biology approach, using proteomics and genomics to examine the development of drug tolerance to EGFR inhibitors in EGFR-mutant lung adenocarcinoma cells and BRAF inhibitors in BRAF-mutant melanoma cells...
February 29, 2024: Cancers
https://read.qxmd.com/read/38462625/safety-and-tolerability-of-atogepant-for-the-preventive-treatment-of-migraine-a-post-hoc-analysis-of-pooled-data-from-four-clinical-trials
#39
RANDOMIZED CONTROLLED TRIAL
Paul Rizzoli, Michael J Marmura, Jennifer Robblee, Jennifer McVige, Sara Sacco, Stephanie J Nahas, Jessica Ailani, Rosa De Abreu Ferreira, Julia Ma, Jonathan H Smith, Brett Dabruzzo, Messoud Ashina
BACKGROUND: Conventional, non-specific preventive migraine treatments often demonstrate low rates of treatment persistence due to poor efficacy or tolerability. Effective, well-tolerated preventive treatments are needed to reduce migraine symptoms, improve function, and enhance quality of life. Atogepant is a migraine-specific oral calcitonin gene-related peptide receptor antagonist that is indicated for the preventive treatment of migraine in adults. This analysis evaluated the safety and tolerability profile of atogepant for the preventive treatment of migraine, including adverse events (AEs) of interest, such as constipation, nausea, hepatic safety, weight changes, and cardiac disorders...
March 11, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38448360/real-world-persistence-with-dolutegravir-lamivudine-versus-bictegravir-emtricitabina-tenofovir-alafenamide-among-people-with-hiv
#40
JOURNAL ARTICLE
Lorena Martín-Zaragoza, Javier Sánchez-Rubio-Ferrández, Alberto Onteniente-González, Marcos Gómez-Bermejo, Sergio Julio Rodríguez-Álvarez, Alfonso Monereo-Alonso, Teresa Molina-García
OBJETIVES: The main objective was to compare the persistence between dolutegravir/lamivudine (DTG/3TC) and bictegravir/emtricitabine/tenofovir-alafenamide (BIC/FTC/TAF) and to analyze reasons for discontinuation. METHODS: We conducted a retrospective, non-interventional, descriptive and longitudinal study. All human immunodeficiency virus (HIV) patients over 18 years treated with DTG/3TC or BIC/FTC/TAF in our center were included. Persistence after first year was compared using the χ2 test...
March 5, 2024: Farmacia Hospitalaria
keyword
keyword
22278
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.